CJC-1295 (without DAC) and GHRP-6 Interaction
CJC-1295 (without DAC) and GHRP-6 have a synergistic interaction with 95% confidence. Amplifies GH pulse when combined. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.
Compound Profiles
CJC-1295 (without DAC)
Short-Acting Growth Hormone Releasing Hormone Analog
Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.
View full profileGHRP-6
Growth Hormone Releasing Peptide-6 | Hexapeptide GHS
GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R1a), the same receptor activated by ghrelin. This initiates a signaling cascade in the hypothalamus and pituitary gland, triggering a rapid pulse of natural GH secretion.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 (without DAC) with GHRP-6?
Yes, CJC-1295 (without DAC) and GHRP-6 can generally be taken together. Amplifies GH pulse when combined.
Is CJC-1295 (without DAC) and GHRP-6 safe together?
Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between CJC-1295 (without DAC) and GHRP-6?
Amplifies GH pulse when combined. This assessment has 95% confidence and is based on documented research data.
How should I time CJC-1295 (without DAC) and GHRP-6?
CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and GHRP-6 has a half-life of 15-60 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.